Surgery Websites
Transplant Surgery »  Meet the Team »  Pediatric Nephrology »  Anthony A. Portale, M.D.
Anthony A. Portale, M.D.

Anthony A. Portale, M.D.

Professor in Residence
Division of Pediatric Nephrology
Department of  Pediatrics
Director, Pediatric Dialysis Program

Contact Information

Academic
533 Parnassus Ave, UC Hall
San Francisco, CA, 94143 
Telephone  415-476-2423 
Fax  415-476-9976
aportale@peds.ucsf.edu

Clinic
Kidney Transplant Program (415) 353-8377
Renal Center (415) 476-2423
Open Popup
  • State University of New York at Buffalo 1974, M.D.
  • UCSF Medical Center, Pediatric Nephrology
  • American Board of Pediatrics - General Pediatrics
  • American Board of Pediatrics - Pediatric Nephrology Subspecialty
  • Acute Kidney Failure
  • Chronic Kidney Disease
  • End-Stage Renal Disease
  • Living Donor Kidney Transplantation
  • Pediatric bone and Mineral Disorders
  • Pediatric Kidney Transplantation
  • Pediatric Transplant Nephrology
  • Bone diseases in children
  • Genetic and acquired disorders of calcium
  • Pphosphorus and vitamin D metabolism

Dr. Anthony A. Portale, a pediatric kidney specialist, is director of the Pediatric Dialysis Program. He is an expert in genetic kidney and renal tubular diseases, disorder of bone and mineral metabolism, and acute kidney failure.

A graduate of St. Joseph's University in Philadelphia, he earned a medical degree at State University of New York at Buffalo and completed a pediatric nephrology fellowship at UCSF Medical Center. His research, funded by the National Institutes of Health, he has produced more than 80 publications in the medical and scientific literature focused on genetic and acquired disorders of calcium, phosphorus and vitamin D metabolism and bone diseases in children.

Most recent publications from a total of 44
  1. Sohn WY, Portale AA, Salusky IB, Zhang H, Yan LL, Ertik B, Shahinfar S, Lee E, Dehmel B, Warady BA. Correction to: An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to View in PubMed
  2. Sohn WY, Portale AA, Salusky IB, Zhang H, Yan LL, Ertik B, Shahinfar S, Lee E, Dehmel B, Warady BA. An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to View in PubMed
  3. Altemose KE, Kumar J, Portale AA, Warady BA, Furth SL, Fadrowski JJ, Atkinson MA. Vitamin D insufficiency, hemoglobin, and anemia in children with chronic kidney disease. Pediatr Nephrol. 2018 Jul 14. View in PubMed
  4. Insogna KL, Briot K, Imel EA, Kamenický P, Ruppe MD, Portale AA, Weber T, Pitukcheewanont P, Cheong HI, Jan de Beur S, Imanishi Y, Ito N, Lachmann RH, Tanaka H, Perwad F, Zhang L, Chen CY, Theodore-Oklota C, Mealiffe M, San Martin J, Carpenter TO. A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis. J Bone Miner Res. 2018 Aug; 33(8):1383-1393. View in PubMed
  5. Sgambat K, Roem J, Mitsnefes M, Portale AA, Furth S, Warady B, Moudgil A. Waist-to-height ratio, body mass index, and cardiovascular risk profile in children with chronic kidney disease. Pediatr Nephrol. 2018 Jun 05. View in PubMed
  6. Carpenter TO, Whyte MP, Imel EA, Boot AM, Högler W, Linglart A, Padidela R, Van't Hoff W, Mao M, Chen CY, Skrinar A, Kakkis E, San Martin J, Portale AA. Burosumab Therapy in Children with X-Linked Hypophosphatemia. N Engl J Med. 2018 05 24; 378(21):1987-1998. View in PubMed
  7. Ng DK, Portale AA, Furth SL, Warady BA, Muñoz A. Time-varying coefficient of determination to quantify the explanatory power of biomarkers on longitudinal GFR among children with chronic kidney disease. Ann Epidemiol. 2018 Aug; 28(8):549-556. View in PubMed
  8. Carpenter TO, Shaw NJ, Portale AA, Ward LM, Abrams SA, Pettifor JM. Rickets. Nat Rev Dis Primers. 2017 Dec 21; 3:17101. View in PubMed
  9. Mitsnefes MM, Betoko A, Schneider MF, Salusky IB, Wolf MS, Jüppner H, Warady BA, Furth SL, Portale AA. FGF23 and Left Ventricular Hypertrophy in Children with CKD. Clin J Am Soc Nephrol. 2018 Jan 06; 13(1):45-52. View in PubMed
  10. Portale AA, Wolf MS, Messinger S, Perwad F, Jüppner H, Warady BA, Furth SL, Salusky IB. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children. Clin J Am Soc Nephrol. 2016 11 07; 11(11):1989-1998. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Anthony A. Portale, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.

Site Directory
    X